págs. 3-5
págs. 7-13
págs. 14-20
Analysis of evidence-rating systems used in meta-analyses of pharmacotherapy
Alberto José Frutos Pérez-Surio, José Manuel Vinuesa Hernando, M. Arenere Mendoza, María Ángeles Allende Bandrés, Maria Aranzazu Alcacera Lopez, Tránsito Salvador Gómez
págs. 21-28
págs. 29-33
Mahtabalsadat Mirjalili, Azita Sadati, Mojdeh Mohamm Adi, Amir-Mohamadi Yaryari, Ehsan Mirzaei, Iman Karimzadeh, Younes Mohamm Adi, Vida Sheikh, Maryam Mehrpooya
págs. 34-43
págs. 44-48
Convalescent plasma therapy for covid-19: A review
págs. 49-58
Pembrolizumab-axitinib for first-line treatment of advanced renal-cell carcinoma
Carmen Lucía Muñoz Cid, Andres Sanchez Ruiz, Raquel Claramunt García
págs. 59-62
Periostitis after prolonged use of alprostadil in newborns with congenital cyanotic heart disease: Case reports
Ana Beatriz Dantas Gomes, Flavia Evelyn Medeiros Fernandes, Ravana Alves da Silva Járdila, Danillo José Ciryllo Silva Noya, Ana Flávia de Melo Maia Bezerra, José Jorge Maciel Neto, Rand Randall Martins
págs. 63-66
Ras and covid-19: Latest evidence
págs. 67-67




© 2001-2026 Fundación Dialnet · Todos los derechos reservados